A naukri.com initiative
Bioengineer
3d
375
Image Credit: Bioengineer
BAY-876 Blocks GLUT1, Triggers Cancer Cell Death
- In a recent study, researchers discovered the potent anti-cancer effects of BAY-876, a selective inhibitor targeting the GLUT1 protein in colorectal cancer cells.
- BAY-876 showed a significant inhibition of cell proliferation and reduced GLUT1 protein expression in various colorectal cancer cell lines.
- Despite lowered glucose uptake, cells treated with BAY-876 exhibited increased mitochondrial respiration and elevated levels of reactive oxygen species.
- The rise in reactive oxygen species led to enhanced apoptosis rates in colorectal cancer cells, contributing to cell death.
- In mouse xenograft models, BAY-876 demonstrated potent tumor growth inhibition and targeted effectiveness by suppressing GLUT1 expression.
- This study sheds light on the relationship between cancer metabolism and therapeutic intervention, with BAY-876 disrupting metabolic pathways vital for cancer cell survival.
- The research highlights the potential of targeting GLUT1 inhibition as a strategy for combating colorectal cancer and other GLUT1-overexpressing tumors.
- The findings suggest that BAY-876 could be paired with other agents to enhance the anti-tumor response and overcome resistance mechanisms.
- BAY-876's specificity for cancer cells and its impact on tumor metabolism present promising avenues for future cancer treatment strategies.
- This research signifies a shift towards metabolism-centered cancer therapies, emphasizing the importance of targeting cancer cell metabolism to improve treatment outcomes.
Read Full Article
22 Likes
For uninterrupted reading, download the app